THBD and Disseminated intravascular coagulation: Recombinant human soluble thrombomodulin (ART-123, Asahi Kasei Pharma Co., Tokyo, Japan), a novel anticoagulant, was approved in Japan in 2008 for patients with disseminated intravascular coagulation (DIC) (2–4).